EastWest Bioscience Inc.

CVE: EAST


Canadian symbol: EAST.V
US symbol: HBOSF

Currency in CAD

Valuation Measures

Market Cap (intraday) 53.24M
Enterprise Value 35.11M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2.55
Price/Book (mrq)N/A
Enterprise Value/Revenue 34.02
Enterprise Value/EBITDA 6-3.67

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-41.67%
S&P500 52-Week Change 35.66%
52 Week High 30.0850
52 Week Low 30.0100
50-Day Moving Average 30.0416
200-Day Moving Average 30.0279

Share Statistics

Avg Vol (3 month) 31.1M
Avg Vol (10 day) 3223.86k
Shares Outstanding 592.61M
Float 65.2M
% Held by Insiders 125.34%
% Held by Institutions 10.00%
Shares Short (Jun. 29, 2020) 444.1k
Short Ratio (Jun. 29, 2020) 40.06
Short % of Float (Jun. 29, 2020) 4N/A
Short % of Shares Outstanding (Jun. 29, 2020) 40.05%
Shares Short (prior month May 28, 2020) 4862.98k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.20
Trailing Annual Dividend Yield 3571.43%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jul. 30, 2019
Most Recent Quarter (mrq)Apr. 29, 2020

Profitability

Profit Margin -162.32%
Operating Margin (ttm)-120.76%

Management Effectiveness

Return on Assets (ttm)-22.97%
Return on Equity (ttm)-247.58%

Income Statement

Revenue (ttm)1.27M
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-71.00%
Gross Profit (ttm)416.62k
EBITDA -1.39M
Net Income Avi to Common (ttm)-2.06M
Diluted EPS (ttm)-0.0250
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)137.2k
Total Cash Per Share (mrq)0
Total Debt (mrq)2.28M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.73
Book Value Per Share (mrq)-0.00

Cash Flow Statement

Operating Cash Flow (ttm)-409.29k
Levered Free Cash Flow (ttm)397.98k

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
EAST.V
EastWest Bioscience
6 months ago
EAST.V
EastWest Bioscience
7 months ago
EAST.V
EastWest Bioscience
7 months ago
EAST.V
EastWest Bioscience
7 months ago
EAST.V
EastWest Bioscience
7 months ago
EAST.V
EastWest Bioscience
7 months ago
EAST.V
EastWest Bioscience
7 months ago
EAST.V
EastWest Bioscience
9 months ago
EAST.V
EastWest Bioscience
9 months ago
EAST.V
EastWest Bioscience
10 months ago
EAST.V
EastWest Bioscience
11 months ago
EAST.V
EastWest Bioscience
1 year ago
EAST.V
EastWest Bioscience
1 year ago
EAST.V
EastWest Bioscience
1 year ago
EAST.V
EastWest Bioscience
1 year ago
EAST.V
EastWest Bioscience
1 year ago
EAST.V
EastWest Bioscience
1 year ago
EAST.V
EastWest Bioscience
1 year ago
EAST.V
EastWest Bioscience
1 year ago
EAST.V
EastWest Bioscience
1 year ago
EAST.V
EastWest Bioscience
1 year ago
EAST.V
EastWest Bioscience
1 year ago
EAST.V
EastWest Bioscience
1 year ago
EAST.V
EastWest Bioscience
1 year ago
EAST.V
EastWest Bioscience
1 year ago
EAST.V
EastWest Bioscience
1 year ago
EAST.V
EastWest Bioscience
1 year ago
EAST.V
EastWest Bioscience
1 year ago
EAST.V
EastWest Bioscience
1 year ago
EAST.V
EastWest Bioscience
1 year ago
EAST.V
EastWest Bioscience
1 year ago
EAST.V
EastWest Bioscience
1 year ago
EAST.V
EastWest Bioscience
1 year ago
EAST.V
EastWest Bioscience
1 year ago

Analysts data is not available


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
25.34%% of Shares Held by All Insider
0.00%% of Shares Held by Institutions
0.00%% of Float Held by Institutions
0Number of Institutions Holding Shares
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by EastWest Bioscience Inc.


EastWest Bioscience Reports Third Quarter Fiscal 2020 Financial Results

EastWest Bioscience Reports Third Quarter Fiscal 2020 Financial Results

Key highlights of third quarter of 2020 fiscal year Total expenses for the three months ended were $520,274 as compared to $1,158,648 for the same period in the prior year, a decrease of $597,327.The Company reported total revenue of $231,248, as compared to $699,991 in the prior year, a decrease of $468,743. This was due to COVID-19 rela... Read More...
EastWest Bioscience Announces Closing of Private Placement and Settlement of Debts for Shares

EastWest Bioscience Announces Closing of Private Placement and Settlement of Debts for Shares

PENTICTON, BC / ACCESSWIRE / June 25, 2020 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) is pleased to announce that further to the Company's press release dated June 18, 2020, the Company has closed a private placement financing with the issuance of 1,992,727 common shares at a price of $0.05 per common share for aggregate... Read More...
EastWest Bioscience Receives Additional Health Canada Approval for Hand Sanitizer

EastWest Bioscience Receives Additional Health Canada Approval for Hand Sanitizer

PENTICTON, BC / ACCESSWIRE / June 2, 2020 / EastWest Bioscience's ("EastWest") (EAST.V) manufacturing subsidiary, Orchard Vale Naturals ("Orchard Vale"), has received additional Health Canada approval for hand sanitizer. This will secure our supply of material required to meet the market demand.When EastWest entered the hand sanitizer spa... Read More...
EastWest BioScience Supplement Manufacturing Division Expands Production to Meet Increased Demand During Pandemic

EastWest BioScience Supplement Manufacturing Division Expands Production to Meet Increased Demand During Pandemic

PENTICTON, BC / ACCESSWIRE / May 20, 2020 / EastWest Bioscience's ("EastWest") (EAST.V) manufacturing subsidiary, Orchard Vale Naturals ("Orchard Vale"), has seen a substantial increase in its manufacturing orders due to surging demand for health and wellness products during the COVID-19 pandemic.Currently, Orchard Vale's production calen... Read More...
Eastwest Reports Improved Financial Results For Second Quarter Of Fiscal 2020

Eastwest Reports Improved Financial Results For Second Quarter Of Fiscal 2020

PENTICTON, British Columbia, April 02, 2020 -- EastWest Bioscience Inc. (the “Company” or “EastWest”) (TSX.V: EAST) has released its second quarter results for the three months ending January 31, 2020.Financial results for the second quarter of 2020 The Company reported revenues for the three months ended January 31, 2020 (“Q2 2020”) were... Read More...
EastWest Files First Quarter 2020 Interim Financial Statements and Provides Update Regarding Management Cease-Trade Order

EastWest Files First Quarter 2020 Interim Financial Statements and Provides Update Regarding Management Cease-Trade Order

VANCOUVER, BC / ACCESSWIRE / February 11, 2020 / EastWest Bioscience Inc. ("EastWest" or the "Corporation") announces that it filed its interim financial statements for the three months ended October 31, 2019, related management discussion and analysis and applicable officer certificates (collectively, the "Quarter One Filings"). The Inte... Read More...
Construction Completed on EastWest's Kentucky, USA CBD Processing and Bottling Line

Construction Completed on EastWest’s Kentucky, USA CBD Processing and Bottling Line

LEBANON, KY / ACCRESSWIRE / February 6, 2020 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) announces that, further to its News Release on November 27th, the Company is pleased to announce that construction is completed on its CBD processing and bottling line in Lebanon, Kentucky. The CBD manufacturing line is part of its 50... Read More...
EastWest Files Audited 2019 Annual Financial Statements and Provides Fifth Status Report Regarding Management Cease-Trade Order

EastWest Files Audited 2019 Annual Financial Statements and Provides Fifth Status Report Regarding Management Cease-Trade Order

VANCOUVER, BC / ACCESSWIRE / January 31, 2020 / EastWest Bioscience Inc. (EAST.V) ("EastWest" or the "Corporation") announces that it filed its annual consolidated financial statements for the year ended July 31, 2019, related management discussion and analysis and applicable officer certificates (collectively, the "Annual Filings"). The ... Read More...
EastWest Issues Fourth Bi-Weekly Status Report Regarding Management Cease-Trade Order

EastWest Issues Fourth Bi-Weekly Status Report Regarding Management Cease-Trade Order

VANCOUVER, BC / ACCESSWIRE / January 23, 2020 / EastWest Bioscience Inc. (EAST.V) ("EastWest" or the "Corporation") provides this bi-weekly default status report in accordance with National Policy 12-203 - Cease Trade Orders for Continuous Disclosure Defaults ("NP 12-203"). In its initial default announcement of November 29, 2019 (the "De... Read More...
EastWest Issues Third Bi-weekly Status Report Regarding Management Cease-Trade Order

EastWest Issues Third Bi-weekly Status Report Regarding Management Cease-Trade Order

VANCOUVER, BC / ACCESSWIRE / January 9, 2020 / EastWest Bioscience Inc. (EAST.V) ("EastWest" or the "Corporation") provides this bi-weekly default status report in accordance with National Policy 12-203 - Cease Trade Orders for Continuous Disclosure Defaults ("NP 12-203"). In its initial default announcement of November 29, 2019 (the "Def... Read More...
EastWest Issues Second Bi-Weekly Status Report Regarding Management Cease-Trade Order

EastWest Issues Second Bi-Weekly Status Report Regarding Management Cease-Trade Order

VANCOUVER, BC / ACCESSWIRE / December 27, 2019 / EastWest Bioscience Inc. ("EastWest" or the "Corporation") provides this bi-weekly default status report in accordance with National Policy 12-203 - Cease Trade Orders for Continuous Disclosure Defaults ("NP 12-203"). In its initial default announcement of November 29, 2019 (the "Default No... Read More...
EastWest Bioscience to Acquire Shares of 1123573 BC Ltd. and Orchard Valley Naturals Ltd.

EastWest Bioscience to Acquire Shares of 1123573 BC Ltd. and Orchard Valley Naturals Ltd.

VANCOUVER, BC / ACCESSWIRE / December 18, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) announces that it has entered a share purchase agreement (the "Agreement") with Darryl Sangster, Aquila Health Corp. and Sangster's Real Estate Corp. (collectively, the "Sangster Parties") for the purchase of shares of 1123573 BC Lt... Read More...
EastWest Issues Bi-Weekly Status Report Regarding Management Cease-Trade Order

EastWest Issues Bi-Weekly Status Report Regarding Management Cease-Trade Order

VANCOUVER, BC / ACCESSWIRE / December 12, 2019 / Eastwest Bioscience Inc. ("Eastwest" or the "Corporation") provides this bi-weekly default status report in accordance with National Policy 12-203 - Cease Trade Orders for Continuous Disclosure Defaults ("NP 12-203"). In its initial default announcement of November 29, 2019 (the "Default No... Read More...
EastWest Bioscience Continues Expansion into the US market with the Construction on its CBD Processing and Bottling Line Nearing Completion

EastWest Bioscience Continues Expansion into the US market with the Construction on its CBD Processing and Bottling Line Nearing Completion

LEBANON, KY / ACCESSWIRE / November 27, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) announces that, further to its News Release on June 20th, the Company is pleased to announce that construction is nearing completion on its CBD processing and bottling line in Lebanon, Kentucky. The CBD manufacturing line is part of i... Read More...
InnerScope Hearing Technologies Inc. (OTCQB: INND) Establishes a Distribution, Warehousing, and Manufacturing Agreement in Canada and the United States with EASTWEST BIOSCIENCE INC. (TSX.V: EAST)

InnerScope Hearing Technologies Inc. (OTCQB: INND) Establishes a Distribution, Warehousing, and Manufacturing Agreement in Canada and the United States with EASTWEST BIOSCIENCE INC. (TSX.V: EAST)

EastWest Bioscience Inc. Wednesday, November 6, 2019 12:44 PM EASTWEST BIOSCIENCE INC. and InnerScope Hearing Technologies Inc. have entered into an Agreement for both companies to establish distribution and marketing rights to include warehousing and distribution facilities based in Canada and the Un... Read More...
InnerScope Hearing Technologies (OTCQB: INND) Establishes a Distribution, Warehousing, and Manufacturing Agreement in Canada and the United States with EASTWEST BIOSCIENCE (TSX.V: EAST)  

InnerScope Hearing Technologies (OTCQB: INND) Establishes a Distribution, Warehousing, and Manufacturing Agreement in Canada and the United States with EASTWEST BIOSCIENCE (TSX.V: EAST)  

InnerScope and EASTWEST BIOSCIENCE, a Canadian public company, have entered into an Agreement for both companies to establish distribution and marketing rights to include warehousing and distribution facilities based in Canada and the United StatesROSEVILLE, Calif. and VANCOUVER, B.C., Nov. 06, 2019 -- via OTC PR WIRE -- InnerScope Hearin... Read More...
EastWest Bioscience Continues Expansion in US with Its First Production Run of CBD Pet Products

EastWest Bioscience Continues Expansion in US with Its First Production Run of CBD Pet Products

LEBANON, KN / ACCESSWIRE / October 30, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) announces that, further to its News Release on July 23rd, the Company has completed the first production run of its CBD Pet Treats for the US Market. The premium CBD used in these CBD pet treats was supplied and produced through its jo... Read More...
EastWest Bioscience Signs Distribution and Broker Deal with Rise North America Based in the United States

EastWest Bioscience Signs Distribution and Broker Deal with Rise North America Based in the United States

EastWest Bioscience Inc. Tuesday, September 10, 2019 10:47 AM VANCOUVER, BC / ACCESSWIRE / September 10, 2019 / EastWest Bioscience (the “Company” or “EastWest”) (TSXV: EAST) announces that it has signed a distribution and broker agreement with RISE North America (“RISE NA”) headquartered in Annapolis... Read More...
EastWest Bioscience to Enter the People's Republic of China with Its Full Line of Hemp-Based Products

EastWest Bioscience to Enter the People’s Republic of China with Its Full Line of Hemp-Based Products

EastWest Bioscience Inc. Thursday, August 15, 2019 10:46 AM VANCOUVER, BC / ACCESSWIRE / August 15, 2019 / EastWest Bioscience (the “Company” or “EastWest”) (TSXV:EAST) announces that it is in the final stages of obtaining it’s Business License to sell products into the People’s Republic of China thro... Read More...
EastWest Bioscience Signs Letter of Intent with Pet Tonics.

EastWest Bioscience Signs Letter of Intent with Pet Tonics.

VANCOUVER, BC / ACCESSWIRE / August 1, 2019 / EastWest Bioscience (the “Company” or “EastWest”) (EAST.V) has signed an LOI with Pet Tonics, LLC, DBA Paws Effect (“Paws”), located in Coppell, TX USA (pawseffect.com). Partnering with strong brands is a significant part of EastWest’s overall strategy to ensure a larger footprint in the retai... Read More...
EastWest USA Received First Batch of Full Spectrum CBD Oil from Azema Sciences for CBD Pet Treats

EastWest USA Received First Batch of Full Spectrum CBD Oil from Azema Sciences for CBD Pet Treats

VANCOUVER, BC / ACCESSWIRE / July 23, 2019 / EastWest Bioscience (the “Company” or “EastWest”) (EAST.V) announces that, further to its News Releases on April 26th and June 25th, 2019, that the Company has received the first batch of its Full Spectrum CBD Oil for its initial pet orders for the US Market from its preferred supply and distri... Read More...
EastWest Science USA Signs Mutual US Distribution Agreement with CBD Manufacturer GM Health Wholesale

EastWest Science USA Signs Mutual US Distribution Agreement with CBD Manufacturer GM Health Wholesale

VANCOUVER, BC / ACCESSWIRE / June 27, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) announces that its subsidiary EastWest Science USA has signed a mutual distributor agreement with GM Health Wholesale ("GM Health") (www.gmhempco.com), a Kentucky company and a leading manufacturer and wholesaler of CBD Tinctures, Cream... Read More...
EastWest Bioscience Continues Expansion in Western Canada Through Avafina Pet Products

EastWest Bioscience Continues Expansion in Western Canada Through Avafina Pet Products

VANCOUVER, BC / ACCESSWIRE / June 24, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) announces that it has partnered with Avafina Pet Products ("Avafina") (www.avafinapet.com) to distribute its Natural Pet Science line of pet treats into more than 300 stores across Western Canada. Avafina's passionate and knowledgeable ... Read More...
EastWest Bioscience Signs Definitive Joint Venture Agreement with Azema Sciences; US Expansion Story Continues

EastWest Bioscience Signs Definitive Joint Venture Agreement with Azema Sciences; US Expansion Story Continues

VANCOUVER, BC / ACCESSWIRE / June 20, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) announces that, further to its News Release on April 30th, 2019 that the Company has signed a Definitive Agreement with Azema Sciences Inc. ("Azema" or "Azema Sciences") to Joint Venture on a preferred supply and distribution agreement,... Read More...
DTC Application Update: EastWest Bioscience Passes Due Diligence for FINRA Form 15c-211

DTC Application Update: EastWest Bioscience Passes Due Diligence for FINRA Form 15c-211

VANCOUVER, BC / ACCESSWIRE / June 19, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) announces that, further to its News Release on May 7th 2019, it has passed third party due diligence pursuant to FINRA Rule 15c2‐11 ("Form 211"), as part of the Company's DTC application. Form 211 clearance is important as it requires t... Read More...
EastWest Bioscience Continues Global Expansion Through a Distribution Agreement with New Zealand Hemp Brokers

EastWest Bioscience Continues Global Expansion Through a Distribution Agreement with New Zealand Hemp Brokers

VANCOUVER, BC / ACCESSWIRE / June 18, 2019 / EastWest Bioscience Inc. (the "Company" or "EastWest") (EAST.V) announces that it has signed a distributor agreement with New Zealand Hemp Brokers (NZHB) (www.nzhempbrokers.com), a leading wholesaler and New Zealand's only specialist Hemp Broker with reach into important key markets in New Zeal... Read More...
EastWest Bioscience Receives TSX Approval for Operations in 20 Additional US States.

EastWest Bioscience Receives TSX Approval for Operations in 20 Additional US States.

VANCOUVER, BC / ACCESSWIRE / June 12, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) expands into 20 Additional US States with TSX approval.On June 6th, 2019, the TSX Venture Exchange gave EastWest Bioscience Inc. the green light to sell its products containing CBD into 20 Additional States in addition to the previous a... Read More...
EastWest Bioscience Signs Letter of Intent to Joint Venture with Continental Agro Trade Corporation a Canadian Industrial Hemp Grower

EastWest Bioscience Signs Letter of Intent to Joint Venture with Continental Agro Trade Corporation a Canadian Industrial Hemp Grower

EastWest BioScience Group Thursday, May 16, 2019 8:30 AM VANCOUVER, BC / ACCESSWIRE / May 15, 2019 / EastWest Bioscience (the "Company"or "EastWest") (TSX.V: EAST) announces that on May 13, 2019 they signed a Letter of Intent to joint venture with Continental Agro Trade Corporation ("Continental") to ... Read More...
EastWest Bioscience Inc. Announces Submission of DTC and OTCQB Venture Market Applications

EastWest Bioscience Inc. Announces Submission of DTC and OTCQB Venture Market Applications

VANCOUVER, BC / ACCESSWIRE / May 7, 2019 / EastWest BioScience Inc. ("Company" or "EastWest") (EAST.V) announces its eligibility to The Depository Trust Company ("DTC") for trading its shares on the OTC Market has been established and subsequently the Company has submitted all required applications. In parallel, the Company has submitted ... Read More...
EastWest Bioscience Signs Joint Venture Intent with US CBD Manufacturer Azema Sciences Inc.

EastWest Bioscience Signs Joint Venture Intent with US CBD Manufacturer Azema Sciences Inc.

VANCOUVER, BC / ACCESSWIRE / April 30, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) announces that on April 29, 2019 they signed an LOI with Azema Sciences Inc. ("Azema" or "Azema Sciences") to Joint Venture on a preferred supply and distribution agreement for bulk CBD and finished CBD products throughout the US and G... Read More...
EastWest Bioscience Adds to CBD Pet Product Line and Leverages FDA Green Light on Hemp Seed in the USA

EastWest Bioscience Adds to CBD Pet Product Line and Leverages FDA Green Light on Hemp Seed in the USA

VANCOUVER, BC / ACCESSWIRE / April 26, 2019 / EastWest Bioscience (the "Company"or "EastWest") (EAST.V) announces four additional products to its Natural Pet Science line, both in Canada and the USA, with CBD included in the USA destined products and which will be marketed to CBD permitted jurisdictions.Over shadowed by the significance o... Read More...
EastWest Bioscience Incorporates US Company in Kentucky for US Operations and CBD Product Development

EastWest Bioscience Incorporates US Company in Kentucky for US Operations and CBD Product Development

VANCOUVER, BC / ACCESSWIRE / April 17, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) is moving rapidly on the recent TSX-V approval allowing EastWest to operate in the USA and announces today its incorporation of EastWest Science USA (EastWest USA), a wholly owned operational subsidiary focussed on CBD consumer product... Read More...
EastWest Bioscience Restructures its Board for Expansion into the US and EU CBD Markets

EastWest Bioscience Restructures its Board for Expansion into the US and EU CBD Markets

VANCOUVER, BC / ACCESSWIRE / April 15, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) announces today the appointment of two new independent Directors, Paul Mandl and Jeff Bierman, to the Board. Both these new board members will help to ensure the Company is well-equipped to efficiently execute its expansion into the US... Read More...
EastWest Bioscience Receives TSX Approval for Operations in Kentucky, USA with Eight New CBD Products

EastWest Bioscience Receives TSX Approval for Operations in Kentucky, USA with Eight New CBD Products

VANCOUVER, BC / ACCESSWIRE / April 10, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) expands into Kentucky, USA with TSX approval.On April 1st, 2019, the TSX Venture Exchange gave EastWest Bioscience Inc. the green light to sell its products containing CBD in Kentucky, USA. Until recently, because of rules imposed by t... Read More...
EastWest Comments on 2Q Financial Statements and Expands on Vision, Strategy, and Execution

EastWest Comments on 2Q Financial Statements and Expands on Vision, Strategy, and Execution

VANCOUVER, BC / ACCESSWIRE / April 8, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) expands on its vision, strategy, and outlook for the future and comments on its 2Q financial results for the three months ended January 31, 2019."It has been a very busy operational quarter," explains Rodney Gelineau, CEO of Eastwest Bi... Read More...
A Message from the CEO - EastWest's Corporate Update on its Vision, Strategy, and Execution

A Message from the CEO – EastWest’s Corporate Update on its Vision, Strategy, and Execution

VANCOUVER, BC / ACCESSWIRE / March 28, 2019 / EastWest Bioscience Inc. (the "Company" or "EastWest") (EAST.V) President and CEO Rodney Gelineau gives a corporate update.Dear Shareholders,The path to the Canadian and US Hemp and CBD markets is nothing short of exhilarating. We have made key strategic decisions for driving our future vision... Read More...
EastWest Bioscience Receives First Scheduled Purchase Order from Major Pet Products Distributor Natural Pet Distributors

EastWest Bioscience Receives First Scheduled Purchase Order from Major Pet Products Distributor Natural Pet Distributors

EastWest Bioscience Inc. Thursday, March 7, 2019 12:41 PM VANCOUVER, BC / ACCESSWIRE / March 7, 2019 / EastWest Bioscience Inc. (the "Company" or "EastWest") (TSX-V: EAST) has received its first order from Natural Pet Distributors ("NPD") (www.naturalpetdistributors.com) one of its major eastern Canad... Read More...
EastWest Bioscience Receives New PO’s from Global Retailer the TJX Companies Inc to Increase Canada Wide Distribution

EastWest Bioscience Receives New PO’s from Global Retailer the TJX Companies Inc to Increase Canada Wide Distribution

EastWest Bioscience Inc. Friday, March 1, 2019 12:25 PM VANCOUVER, BC / ACCESSWIRE / March 1, 2019 / EastWest Bioscience Inc. (the "Company" or "EastWest") (TSX-V: EAST) announces that the Company has received several new purchase orders for its hemp-based consumer goods from global retailer The TJX C... Read More...
EastWest Bioscience Attends CHFA West Natural Health Product Show to Introduce its Newest Hemp-based Food and Body Care Products

EastWest Bioscience Attends CHFA West Natural Health Product Show to Introduce its Newest Hemp-based Food and Body Care Products

EastWest BioScience Group Friday, February 22, 2019 8:30 AM VANCOUVER. BC / ACCESSWIRE / February 22, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) announces it will be attending the Canadian Health Foods Association (CHFA) West Tradeshow at the Vancouver Convention Centre in ... Read More...
Coming Soon.

Delayed data (1h)


Share this page